• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞毒性T淋巴细胞抗原4(CTLA-4)干扰细胞外信号调节激酶(ERK)和Jun氨基末端激酶(JNK)的激活,但不影响T细胞受体ζ链和ZAP70的磷酸化。

Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70.

作者信息

Calvo C R, Amsen D, Kruisbeek A M

机构信息

Division of Immunology, The Netherlands Cancer Institute, Amsterdam.

出版信息

J Exp Med. 1997 Nov 17;186(10):1645-53. doi: 10.1084/jem.186.10.1645.

DOI:10.1084/jem.186.10.1645
PMID:9362525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2199134/
Abstract

Cytotoxic T lymphocyte antigen 4 (CTLA-4) is an important regulator of T cell homeostasis. Ligation of this receptor leads to prominent downregulation of T cell proliferation, mainly as a consequence of interference with IL-2 production. We here report that CTLA-4 engagement strikingly selectively shuts off activation of downstream T cell receptor (TCR)/CD28 signaling events, i.e., activation of the microtubule-associated protein kinase (MAPKs) ERK and JNK. In sharp contrast, proximal TCR signaling events such as ZAP70 and TCR-zeta chain phosphorylation are not affected by CTLA-4 engagement on activated T cells. Since activation of the ERK and JNK kinases is required for stimulation of interleukin (IL)-2 transcription, these data provide a molecular explanation for the block in IL-2 production imposed by CTLA-4.

摘要

细胞毒性T淋巴细胞抗原4(CTLA-4)是T细胞稳态的重要调节因子。该受体的结合导致T细胞增殖显著下调,主要是由于干扰白细胞介素-2(IL-2)的产生。我们在此报告,CTLA-4的结合显著选择性地关闭下游T细胞受体(TCR)/CD28信号事件的激活,即微管相关蛋白激酶(MAPK)ERK和JNK的激活。与之形成鲜明对比的是,近端TCR信号事件,如ZAP70和TCR-zeta链磷酸化,不受激活的T细胞上CTLA-4结合的影响。由于ERK和JNK激酶的激活是刺激白细胞介素(IL)-2转录所必需的,这些数据为CTLA-4对IL-2产生的阻断提供了分子解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5b/2199134/4310633f0c15/JEM.970946f4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5b/2199134/82bccda18f75/JEM.970946f1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5b/2199134/ebbfa844facf/JEM.970946f2t.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5b/2199134/b0e323facfd5/JEM.970946f3t.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5b/2199134/4310633f0c15/JEM.970946f4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5b/2199134/82bccda18f75/JEM.970946f1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5b/2199134/ebbfa844facf/JEM.970946f2t.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5b/2199134/b0e323facfd5/JEM.970946f3t.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5b/2199134/4310633f0c15/JEM.970946f4a.jpg

相似文献

1
Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70.细胞毒性T淋巴细胞抗原4(CTLA-4)干扰细胞外信号调节激酶(ERK)和Jun氨基末端激酶(JNK)的激活,但不影响T细胞受体ζ链和ZAP70的磷酸化。
J Exp Med. 1997 Nov 17;186(10):1645-53. doi: 10.1084/jem.186.10.1645.
2
CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases.细胞毒性T淋巴细胞相关抗原4(CTLA-4)通过抑制ζ链相关蛋白激酶70(ZAP-70)酪氨酸(Tyr)319位点的磷酸化来抑制静息人CD4(+) T细胞中的近端T细胞受体(TCR)信号传导:酪氨酸磷酸酶的潜在作用
J Immunol. 2002 May 1;168(9):4420-9. doi: 10.4049/jimmunol.168.9.4420.
3
The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation.细胞毒性T淋巴细胞相关抗原4(CTLA-4)的抑制功能并不需要其酪氨酸磷酸化。
J Immunol. 2000 Jan 1;164(1):49-55. doi: 10.4049/jimmunol.164.1.49.
4
Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ligand-deficient mice.前沿:细胞毒性T淋巴细胞相关抗原4(CTLA-4,即CD152)对来自受体/配体缺陷小鼠的CD4+ T细胞中的丝裂原活化蛋白激酶(细胞外信号调节激酶和c-Jun氨基末端激酶)具有差异性调节作用。
J Immunol. 2002 Oct 1;169(7):3475-9. doi: 10.4049/jimmunol.169.7.3475.
5
TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway.TCR和CD28通过ZAP-70与Vav/Rac-1-/PAK-1/p38丝裂原活化蛋白激酶信号通路的激活相偶联。
J Immunol. 1999 Jul 15;163(2):844-53.
6
A regulatory role for cytoplasmic YVKM motif in CTLA-4 inhibition of TCR signaling.细胞质YVKM基序在CTLA-4抑制TCR信号传导中的调节作用。
Eur J Immunol. 2001 Jul;31(7):2042-50. doi: 10.1002/1521-4141(200107)31:7<2042::aid-immu2042>3.0.co;2-d.
7
Contributions of the T cell receptor-associated CD3gamma-ITAM to thymocyte selection.T细胞受体相关的CD3γ免疫受体酪氨酸活化基序对胸腺细胞选择的作用
J Exp Med. 2002 Jul 1;196(1):1-13. doi: 10.1084/jem.20020268.
8
TCR subunit specificity of CTLA-4-mediated signaling.CTLA-4介导信号传导的TCR亚基特异性。
J Leukoc Biol. 2003 Dec;74(6):1102-7. doi: 10.1189/jlb.0503198. Epub 2003 Sep 12.
9
Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in jurkat T cells. Evidence for the importance of Ras in a pathway that is controlled by dual receptor stimulation.通过在Jurkat T细胞中诱导稳定表达显性负性和显性活性丝裂原活化蛋白激酶激酶激酶来调控白细胞介素-2转录。Ras在由双受体刺激控制的信号通路中的重要性的证据。
J Biol Chem. 1996 Nov 1;271(44):27366-73. doi: 10.1074/jbc.271.44.27366.
10
Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.酪氨酸磷酸酶SYP与CTLA-4结合对T细胞受体信号传导的调节
Science. 1996 May 24;272(5265):1170-3. doi: 10.1126/science.272.5265.1170.

引用本文的文献

1
Molecular biology of the novel anticancer medications: a focus on kinases inhibitors, biologics and CAR T-cell therapy.新型抗癌药物的分子生物学:聚焦激酶抑制剂、生物制剂和嵌合抗原受体T细胞疗法。
Inflamm Res. 2025 Feb 17;74(1):41. doi: 10.1007/s00011-025-02008-5.
2
EGF-Receptor against Amphiregulin (AREG) Influences Costimulatory Molecules on Monocytes and T Cells and Modulates T-Cell Responses.表皮生长因子受体(EGF-R)拮抗 Amphiregulin(AREG)影响单核细胞和 T 细胞的共刺激分子,并调节 T 细胞反应。
J Immunol Res. 2023 Nov 24;2023:8883045. doi: 10.1155/2023/8883045. eCollection 2023.
3
Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials.

本文引用的文献

1
Pillars article: antigen receptor tail clue. Nature. 1989. 338: 383-384.专栏文章:抗原受体尾部线索。《自然》。1989年。第338卷:第383 - 384页。
J Immunol. 2014 May 1;192(9):4015-6.
2
CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion.细胞毒性T淋巴细胞相关抗原4(CTLA-4)与B7分子的相互作用足以共刺激T细胞克隆扩增。
J Exp Med. 1997 Apr 7;185(7):1327-35. doi: 10.1084/jem.185.7.1327.
3
Is CTLA-4 a master switch for peripheral T cell tolerance?细胞毒性T淋巴细胞相关抗原4(CTLA-4)是外周T细胞耐受的主控开关吗?
释放免疫检查点抑制剂对晚期肝细胞癌的疗效:影响因素、策略及正在进行的试验
Front Pharmacol. 2023 Aug 31;14:1261575. doi: 10.3389/fphar.2023.1261575. eCollection 2023.
4
Tumor microenvironment signaling and therapeutics in cancer progression.肿瘤微环境信号与癌症进展中的治疗策略。
Cancer Commun (Lond). 2023 May;43(5):525-561. doi: 10.1002/cac2.12416. Epub 2023 Apr 2.
5
Motility Dynamics of T Cells in Tumor-Draining Lymph Nodes: A Rational Indicator of Antitumor Response and Immune Checkpoint Blockade.肿瘤引流淋巴结中T细胞的运动动力学:抗肿瘤反应和免疫检查点阻断的合理指标
Cancers (Basel). 2021 Sep 15;13(18):4616. doi: 10.3390/cancers13184616.
6
Immune Checkpoints in Cancers: From Signaling to the Clinic.癌症中的免疫检查点:从信号传导到临床应用
Cancers (Basel). 2021 Sep 12;13(18):4573. doi: 10.3390/cancers13184573.
7
Biological Landscape of Triple Negative Breast Cancers Expressing CTLA-4.表达细胞毒性T淋巴细胞相关抗原4的三阴性乳腺癌的生物学图景
Front Oncol. 2020 Aug 5;10:1206. doi: 10.3389/fonc.2020.01206. eCollection 2020.
8
PD-1-Mediated PI3K/Akt/mTOR, Caspase 9/Caspase 3 and ERK Pathways Are Involved in Regulating the Apoptosis and Proliferation of CD4 and CD8 T Cells During BVDV Infection .PD-1 介导的 PI3K/Akt/mTOR、Caspase 9/Caspase 3 和 ERK 通路参与调控 BVDV 感染期间 CD4 和 CD8 T 细胞的凋亡和增殖。
Front Immunol. 2020 Mar 17;11:467. doi: 10.3389/fimmu.2020.00467. eCollection 2020.
9
Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors.免疫疗法的免疫靶点:抑制性T细胞受体。
Methods Mol Biol. 2020;2055:23-60. doi: 10.1007/978-1-4939-9773-2_2.
10
AP-1 Transcription Factors as Regulators of Immune Responses in Cancer.AP-1转录因子作为癌症免疫反应的调节因子
Cancers (Basel). 2019 Jul 23;11(7):1037. doi: 10.3390/cancers11071037.
J Immunol. 1997 Mar 1;158(5):1989-93.
4
Costimulation and autoimmunity.共刺激与自身免疫
Curr Opin Immunol. 1996 Dec;8(6):822-30. doi: 10.1016/s0952-7915(96)80011-2.
5
The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP?受体介导的抑制性信号传导这一新兴领域:SHP 还是 SHIP?
Cell. 1996 Dec 13;87(6):961-4. doi: 10.1016/s0092-8674(00)81790-0.
6
Requirement of phospholipase C gamma, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways.血小板衍生生长因子(PDGF)诱导DNA合成对磷脂酶Cγ、酪氨酸磷酸酶Syp以及衔接蛋白Shc和Nck的需求:Ras依赖性和Ras非依赖性途径存在的证据
EMBO J. 1996 Sep 16;15(18):4940-8.
7
Mitogen-activated protein kinase cascades and regulation of gene expression.丝裂原活化蛋白激酶级联反应与基因表达调控
Curr Opin Immunol. 1996 Jun;8(3):402-11. doi: 10.1016/s0952-7915(96)80131-2.
8
CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis.在实验性变应性脑脊髓炎期间,CTLA-4阻断增强临床疾病和细胞因子产生。
J Immunol. 1996 Aug 15;157(4):1333-6.
9
Composition and function of T-cell receptor and B-cell receptor complexes on precursor lymphocytes.前体淋巴细胞上T细胞受体和B细胞受体复合物的组成与功能。
Curr Opin Immunol. 1996 Apr;8(2):181-90. doi: 10.1016/s0952-7915(96)80056-2.
10
T cell antigen receptor signal transduction pathways.T细胞抗原受体信号转导途径。
Annu Rev Immunol. 1996;14:259-74. doi: 10.1146/annurev.immunol.14.1.259.